🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Serigne Lo

The University of Sydney

ORCID: 0000-0001-5092-5544

Also affiliated with Melanoma Institute Australia

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies”.

Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies

International Journal of Cancer(2020)10.1002/ijc.33312
N/A
4.7DataRank · unranked
113 citations

Joshua D. Cohen, Serigne Lo, Yuxuan Wang, Lu Li, Michael Christie +23 more

Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆

Annals of Oncology(2020)10.1016/j.annonc.2020.04.471
N/A
3.5DataRank · unranked
110 citations

Alexander N. Shoushtari, D Chauhan, David Palmieri, Belinda Lee, Maartje W. Rohaan +20 more

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: Overall survival and updated 5-year results from the randomized DYNAMIC trial.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.108
N/A
0.837DataRank · unranked
15 citations

Yuxuan Wang, Serigne Lo, Kamel Lahouel, Joshua D. Cohen, Rachel Wong +15 more

Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial

Nature Medicine(2025)10.1038/s41591-025-03579-w
N/A
0.691DataRank · unranked
99 citations

Yuxuan Wang, Serigne Lo, Kamel Lahouel, Joshua D. Cohen, Rachel Wong +24 more

Histopathological features of complete pathological response predict recurrence-free survival following neoadjuvant targeted therapy for metastatic melanoma

Annals of Oncology(2020)10.1016/j.annonc.2020.07.016
N/A
0.538DataRank · unranked
35 citations

Chandra Mani Adhikari, Serigne Lo, Robert V. Rawson, Rodabe N. Amaria, Alexander M. Menzies +16 more

Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting

Journal of Translational Medicine(2022)10.1186/s12967-022-03613-2
N/A
0.312DataRank · unranked
7 citations

Richard A. Scolyer, D. Timothy Bishop, Julia Newton‐Bishop, Mark M. Iles, Serigne Lo +14 more

Representativeness of initial skin biopsies showing pure desmoplastic melanoma: implications for management

Pathology(2023)10.1016/j.pathol.2022.12.346
N/A
0.312DataRank · unranked
7 citations

I A Vergara, Jonathan R. Stretch, R.P.M. Saw, John F. Thompson, Serigne Lo +3 more

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator

Journal of Clinical Oncology(2024)10.1200/jco.23.01020
N/A
0DataRank · unranked
16 citations

Isabel Li, Mary‐Ann El Sharouni, J. M. Gardner, Aikaterini Dedeilia, Sydney Ch’ng +17 more

Tumour gene expression signature in primary melanoma predicts long-term outcomes

Nature Communications(2021)10.1038/s41467-021-21207-2
N/A
0DataRank · unranked
70 citations

Dominique‐Laurent Couturier, Jérémie Nsengimana, Nuno A. Fonseca, Matthew Wongchenko, Yibing Yan +21 more

FRAMe: Familial Risk Assessment of Melanoma—a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma

Familial Cancer(2020)10.1007/s10689-020-00209-x
N/A
0DataRank · unranked
7 citations

Serigne Lo, Blake Kelly, Helen Schmid, Anne E. Cust, Jane M. Palmer +5 more

A multicentre study of naevus‐associated melanoma vs. de novo melanoma, tumour thickness and body site differences*

British Journal of Dermatology(2021)10.1111/bjd.19819
N/A
0DataRank · unranked
26 citations

Alan C. Geller, A. Stergiopoulou, Niki Dimou, Serigne Lo, Ulrike Keim +17 more

318MO Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC)

Annals of Oncology(2022)10.1016/j.annonc.2022.07.456
N/A
0DataRank · unranked
14 citations

Jesse Cohen, Kamel Lahouel, Serigne Lo, Y. Wang, Rachel Wong +15 more